Category: atopic dermatitis

According to a new study, dupilumab has been shown to reduce severity and improve quality of life (QoL) in pediatric patients with atopic dermatitis (AD) two weeks after treatment.

According to a new study, a single-strain probiotic was found to have a positive effect on atopic dermatitis (AD) in pediatric patients.

According to a new study, adolescents with atopic dermatitis (AD) are more likely to have their school work adversely affected by their skin condition.

Air pollution and particulate matter are associated with more medical visits for patients with atopic dermatitis (AD), according to a new study.

Online mindfulness training has shown improvements in patient quality of life (QoL) and disease severity in Atopic Dermatitis (AD), according to a new study.

According to a new study, patients and caregivers similarly ranked the importance of factors when choosing whether to participate in eczema clinical trials.

According to a recent study, individuals with atopic dermatitis (AD) and asthma may be more likely to develop osteoarthritis.

According to a new study, sleep disturbances in adults with moderate-to-severe atopic dermatitis (AD) generally improve over time.

New findings show that atopic dermatitis (AD) incidence and prevalence have increased over the last two decades, especially in Black and multiracial children.

Dupilumab was effective in improving disease severity and decreasing severity-associated serum biomarkers in pediatric atopic dermatitis (AD) patients after 28 weeks of treatment, according to real-world evidence from clinical practice.